ACS:180 & ADVIA CENTAUR AFP IMMUNOASSAY— 510(k) K020806

Substantially Equivalent

Bayer Corp.

FDA 510(k) clearance K020806 for ACS:180 & ADVIA CENTAUR AFP IMMUNOASSAY, Substantially Equivalent on 2002-03-27. Applicant: Bayer Corp..

Clearance details

Applicant: Bayer Corp.
Product code: Code LOJ
Advisory panel: Immunology
Date received: 2002-03-12
Decision date: 2002-03-27
Decision: Substantially Equivalent
Clearance type: Special
Location: Medfield, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.